All of WSIPP's research is published on our website. The Publications page includes every report we've released—from our founding in 1983 to the present. Each report entry includes the title, publication date, abstract, any available supplemental materials, and a downloadable PDF.
WSIPP reports are not updated after publication, and any report older than two years is designated with an “Archived” label.
To explore our benefit-cost and meta-analytic findings, please visit the Benefit-Cost section of the website.
Use the search fields below to find specific publications that match certain criteria. If you want to find other information on our website that is not publications, you can use the search field in the navigation bar at the top, or click here to search the entire website.
Found 1 results
The 2018 Washington State Legislature directed WSIPP to conduct a study of single-payer and universal health coverage systems. Our interim report discussed policies to promote universal health care, outlined health care coverage and expenditures in Washington, examined potential effects of implementing single-payer health care, discussed challenges to implementing it, and summarized characteristics of national and state single-payer proposals. Our final report examines universal coverage and single-payer systems in other high-income countries, which have achieved universal coverage and substantially lower health care spending than the US. These other countries, both single- and multi-payer, have mechanisms to control the prices of medical services and pharmaceuticals. They have lower insurer administrative costs and, in the case of single-payer countries, lower provider administrative burdens. These countries also have, to varying degrees, limited the utilization of some high-margin procedures and advanced imaging and discouraged the diffusion of medical technologies and drugs that have modest or uncertain effectiveness. Individuals in these countries have fewer financial barriers to health care and more equitable access to care across income groups than in the US. Finally, the higher US health expenditures do not translate to better health outcomes and quality of care for the entire population.